China Isotope & Radiation Corp. (HK:1763) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Isotope & Radiation Corporation has released its interim financial results for the first half of 2024, showing an increase in revenue from RMB 2,739,483,000 in 2023 to RMB 2,810,279,000. The company also reported a higher profit of RMB 306,673,000 compared to RMB 282,183,000 in the previous year, despite facing higher costs of sales and investments in research and development.
For further insights into HK:1763 stock, check out TipRanks’ Stock Analysis page.